Cargando…
Controlled delivery of BID protein fused with TAT peptide sensitizes cancer cells to apoptosis
BACKGROUND: Low cellular level of BID is critical for viability of numerous cancer cells. Sensitization of cells to anticancer agents by BID overexpression from adenovirus or pcDNA vectors is a proposed strategy for cancer therapy; however it does not provide any stringent control of cellular level...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210496/ https://www.ncbi.nlm.nih.gov/pubmed/25326334 http://dx.doi.org/10.1186/1471-2407-14-771 |